Cytomegalovirus and Tumors: Two Players for One Goal-Immune Escape
Quentin Lepiller1, Kashif Aziz Khan1, §, Vincent Di Martino2, Georges Herbein*, 1
Identifiers and Pagination:Year: 2011
First Page: 60
Last Page: 69
Publisher Id: TOVJ-5-60
Article History:Received Date: 15/2/2011
Revision Received Date: 10/4/2011
Acceptance Date: 12/4/2011
Electronic publication date: 1/6/2011
Collection year: 2011
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Cytomegalovirus (CMV) and the human tumor cell share the same objectives: escape the recognition and destruction by the immune system and establish a state of immune tolerance conducive for their development. For early tumor development, the escape of the first lines of defense of the immune surveillance is a critical step which determines survival or destruction. The presence of CMV on the tumor site and its involvement in carcinogenesis as initiator or promoter is increasingly documented. In this article, we highlight the similarity between mechanisms used by tumors and CMV to circumvent the immune defenses and evade from immune surveillance. We suggest that CMV and tumors help one another for their common objective. CMV gets shelter in immunologically poor environment of the tumor cells. In return CMV, by acting directly on the cancer cell and/or on the tumor microenvironment, provides the tumor cell the ways to promote its immune escape and development of immune tolerance.